Navigation Links
PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
Date:11/24/2008

TORONTO, Nov. 24 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; PREMF.pk) today announced that it has entered into a fully funded collaborative clinical study with one of the world's largest cosmetic companies. PreMD's PREVU* skin cholesterol test will be used in conjunction with one of the cosmetic company's skin care products in a European clinical study. This follows an earlier successful study completed by PreMD with the cosmetic company.

"This is a very positive development for PreMD," said Brent Norton, President and CEO of PreMD. "To engage in collaborations with one of the world's leading cosmetics conglomerates is a significant development which validates our expertise in skin testing, exposes our products' capabilities to new markets, and opens the door to further commercial partnerships. We are excited by the prospect of developing new uses for the product in the cosmetics field and we are hoping to capitalize on these and other opportunities in the near future."

About PreMD Inc.

PreMD Inc. is a leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products include PREVU* POC and PREVU* LT, both non-invasive skin cholesterol tests. The Company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. PreMD's head office is located in Toronto, Ontario and its research and product development facility is at McMaster University in Hamilton, Ontario. For more information about PreMD, please visit www.premdinc.com.

This press release contains forward-looking statements. These statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncerta
'/>"/>

SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
2. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
3. Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
4. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
5. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
6. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
7. ProteoTechs Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimers Disease
8. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
9. Edison Pharma Hits Milestone as A0001 Enters Phase 1 Clinical Development
10. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
11. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ire/ -- TessArae® LLC, a global leader in res... the launch of new integrated product solutions fo...uman hereditary diseases. The combination of Tess...with novel nucleotide sequence basecalling algorit...l targeted mutations in multiple genes of a syndro...
(Date:11/9/2009)...- AMD LASERS just announced that industry leading ... the position of Medical Director. In his new rol...search and development of new soft and hard tissue...nuing education credits, authoring articles for re...turing and seminar engagements. ,, "We are very...
(Date:11/9/2009)...RNewswire/ -- Unwavering from its pursuit of produ...oday,s economic climate, Lutronic, Inc., a leading..., introduces the MOSAIC CO2, a full-featured fract...he MOSAIC CO2 offers many of the features unique t...ing and stamping operation modes and patented Cont...
Breaking Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2AMD LASERS Names Dr. James Jesse as Medical Director 2Lutronic(R) Unleashes the New MOSAIC CO2 2Cell Therapeutics Inc 28CTI 29 to Report Second Quarter Financial Results on August 6 53686 1Climate change poker 3A The barriers which are preventing a global agreement 9478 1Climate change poker 3A The barriers which are preventing a global agreement 9478 2delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9476 1delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9476 2
...ceuticals Inc.,announced today on the occasion of ...International Conference in San Francisco that its...howed synergistic effects,with certain standard ch...7). In vitro data showed significant (p<0.001... cells with combinations of docetaxel and,SF1126, ...
... data presented at AACR-NCI-EORTC ...Cell Therapeutics,Inc. (CTI) (Nasdaq and MTAX: CTI...subsidiary of CTI, announced new preclinical data ...h annual AACR-NCI-EORTC Symposium. "These studies...ic,tumor types with a higher likelihood of demonst...
Other Medicine Technology:Semafore's PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5
(Date:11/9/2009)...ighlighting a commitment to providing long-term he...and digital display technology options, LG Electro...ospital Grade LCD HDTVs this week at the Associati... meeting and exposition (booth #1760). ,, On di...M)" Long-Term Care LCD HDTVs bring a sense of home...
(Date:11/9/2009)...om incapacitated to working again, , ,...imulation of a certain area of the brain may prove... German researchers. , They implanted electrode...0 people. This area of the brain is part of the r...d experiences and puts them in a state of pleasant...
(Date:11/9/2009)...Newswire/ -- Speaker Nancy Pelosi released the fo...dable Health Care for America Act (H.R. 3962) ...dicare Part D costs for people living with HIV/AID...e of 220 to 215: ,, "Effective drug treatments... thousands of Americans living with HIV/AIDS. Howe...
(Date:11/9/2009)...wire/ -- At a time when the 250,000+ eligible Medi...d about finding affordable health insurance, they ..., The Today,s Options® Preferred Provider ...s a cost-effective and comprehensive alternative t... People with Medicare can choose to sign up for t...
(Date:11/9/2009)...Newswire/ -- The American Academy of Physician Ass...ically practicing physician assistants (PAs) pract...e of Representatives for passing Saturday its heal...lth Care for America Act. ,, "We are especially...ower the cost of health care and greatly expand co...
Breaking Medicine News(10 mins):Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2
... Human Services (HHS) and its Centers for Disease ...Infant Immunization Week (NIIW) with events// Apri...the United States are expected to participate in N...local health departments, the United States-Mexico...
...parent failure by official bodies to halt the dist...tories have been incidents caused by E. coli cont...er as well as pet food. Around 200 persons we...ming tainted spinach. Eating contaminated peanut b...
...ences (AIIMS) has developed artificial testis, whi...r, underdeveloped genitals.// Doctors at the...pon over 50 patients suffering from such problems,...two to three-month-old babies suffering from cance...
...ed so high a priority in the minds of concerned he... There are moves to do away with regular school s...ve are contributing to ungainly as well as dangero...Stallings, head of the committee: "Making sure tha...
...ne - ‘The Scientist’ announced the winners of the ...s have been instituted to honor "best-in-class" co...ustry Awards are given to top life science supplie...tive Exchange and The Science Advisory Board. ...
...edication Ranolazine has not been effective in red... as death// , heart attack or recurrent ischemia f...dvances in the treatment of acute coronary syndrom...ciation between ranolazine and prolongation of the...
Other Medicine News:Health News:National Infant Immunization Week Urges Parents to Vaccinate On Time 2Health News:U.S Officials Worried Over Failure In Preventing Food Contamination 2Health News:Artificial Testis Developed by AIIMS a Boon to Suffering Patients 2Health News:Weight Issues In Children-Experts Take Stock 2Health News:Bio-Rad Gets Life Science Industry Awards – 200 2Health News:Bio-Rad Gets Life Science Industry Awards – 200 3Health News:Anti-anginal Drug Not Effective in Reducing Major Cardiac Events 2
...rovides fingertip ratchet disengagement allowing s...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...
...rovides fingertip ratchet disengagement allowing s...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...
...rovides fingertip ratchet disengagement allowing s...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...
...rovides fingertip ratchet disengagement allowing s...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...
Medicine Products: